Summary
One approach to the engineering of functional cardiac tissue for basic studies and potential clinical use involves bioreactor cultivation of dissociated cells on a biomaterial scaffold. Our objective was to develop a scaffold that is (1) highly porous with large intereconnected pores (to facilitate mass transport), (2) hydrophilic (to enhance cell attachment), (3) structurally stable (to withstand the shearing forces during bioreactor cultivation), (4) degradable (to provide ultimate biocompatibility of the tissue graft), and (5) elastic (to enable transmission of contractile forces). The scaffold of choice was made as a composite of poly(Dl-lactide-co-caprolactone), poly(Dl-lactide-co-glycolide) (PLGA), and type I collagen, with open interconnected pores and the average void volume of 80±5%. Neonatal rat heart cells suspended in Matrigel were seeded into the scaffold at a physiologically high density (1.35×108 cells/cm3) and cultivated for 8 d in cartridges perfused with culture medium or in orbitally mixed dishes (25 rpm); collagen sponge (Ultrafoam⋆m) and PLGA sponge served as controls. Construct cellularity, presence of cardiac markers, and contractile properties were markedly improved in composite scaffolds as compared with both controls.
Similar content being viewed by others
References
Agrawal, C. M.; Gabriele, P. E.; Niederauer, G.; Athanasiou, K. A. Fabrication and characterization of pla-pga orthopedic implants. Tissue Eng. 1:241–252; 1995.
Akins, R. E. Can tissue engineering mend broken hearts? Circ. Res. 90:120–122; 2002.
Bader, A.; Schilling, T.; Teebken, O. E.; Brandes, G.; Herden, T.; Steinhoff, G.; Haverich, A. Tissue engineering of heart valves—human endothelial cell seeding of detergent acellularized porcine valves. Eur. J. Cardiothorac. Surg. 14:279–284; 1998.
Bursac, N.; Papadaki, M.; Cohen, R. J.; Schoen, F. J.; Eisenberg, S. R.; Carrier, R.; Vunjak-Novakovic, G.; Freed, L. E. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol. 277:H433-H444; 1999.
Carrier, R. L.; Papadaki, M.; Rupnick, M.; Schoen, F. J.; Bursac, N.; Langer, R.; Freed, L. E.; Vunjak-Novakovic, G. Cardiac tissue engineering: cell seeding, cultivation parameters and tissue construct characterization. Biotechnol. Bioeng. 64:580–589; 1999.
Cima, L. G.; Vacanti, J. P.; Vacanti, C.; Ingber, D.; Mooney, D.; Langer, R. Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113:143–151; 1991.
Dai, N. T.; Williamson, M. R.; Khammo, N.; Adams, E. F.; Coombes, A. G. Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin. Biomaterials 25:4263–4271; 2004.
Dohmen, P. M.; Lembcke A.; Hots, H.; Kivelitz, D.; Konertz, W. F.: Ross operation with a tissue engineered heart valve. Ann. Thorac. Surg. 74:1438–1442; 2002.
Freed, L. E.; Vunjak-Novakovic, G. Culture of organized cell communities. Adv. Drug Deliv. Rev. 33:15–30; 1998.
Freed, L. E.; Vunjak-Novakovic, G.: Tissue engineering bioreactors. In: Lanza, R. P.; Langer, R.; Vacanti, J., ed. Principles of tissue engineering, 2nd ed. San Diego, CA: Academic Press; 2000:143–156.
Hua, F. J.; Kim, G. E.; Lee, J. D.; Son, Y. K.; Lee, D. S. Macroporous poly(llactide) scaffold 1. Preparation of macroporous scaffold by liquidliquid phase separation of a PLLA-dioxane-water system. J. Biomed. Mater. Res. 63:161–167; 2002.
Ishaug-Riley, S. L.; Crane, G. M.; Gurlek, A.; Miller, M. J.; Yasko, A. W.; Yaszemski, M. J.; Mikos, A. G. Ectopic bone formation by marrow stromal osteoblast transplantation using poly(Dl-lactic-co-glycolic acid) foams implanted into the rat mesentery. J. Biomed. Mater. Res. 36:1–8; 1997.
Krupnick, A. S.; Kreisel, D.; Engels, F. H.; Szeto, W. Y.; Plappert, T.; Popmaa, S. H. Flake, A. W.; Rosengard, B. R. A novel small animal model of left ventricular tissue engineering. J. Heart Lung Transplant. 21:233–243; 2002.
Lee, C. H.; Singla, A.; Lee, Y. Biomedical application of collagen. Int. J. Pharm. 221:1–22; 2001.
Leor, J.; Aboulafia-Etzion, S.; Dar, A.; Shapiro, L.; Barbash, I. M.; Battler, A.; Granot, Y.; Cohen, S. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102:III56-III61; 2000.
Orlic, D.; Kajstura, J.; Chimenti, S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705; 2001.
Ozawa, T.; Mickle, D. A.; Weisel, R. D.; Koyama, N.; Ozawa, S.; Li, R. K. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106:1176–1182; 2002.
Papadaki, M.; Bursac, N.; Langer, R.; Merok, J.; Vunjak-Novakovic, G.; Freed, L. E. Tissue engineering of functional cardiac muscle: molecular, structural and electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol. 280:H168-H178; 2001.
Radisic, M.; Euloth, M.; Yang, L.; Langer, R.; Freed, L. E.; Vunjak-Novakovic, G. High density seeding of myocyte cells for tissue engineering. Biotechnol. Bioeng. 82:403–414; 2003.
Radisic, M.; Park, H.; Shing, H.; Consi, T.; Schoen, F. J.; Langer, R.; Freed, L. E.; Vunjak-Novakovic, G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101:18129–18134, 2004a.
Radisic, M.; Yang, L.; Boublik, J.; Cohen, R. J.; Langer, R.; Freed, L. E.; Vunjak-Novakovic, G. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 286:H507-H516; 2004b.
Radisic, M.; Obradovic, B.; Vunjak-Novakovic, G. Functional tissue engineering of cartilage and myocardium: bioreactor aspects. In: Ma, P. X.; Eliseeff, J., ed. Scaffolding in tissue engineering. Marcel Dekker; pp 491–520, 2005.
Shinoka, T.; Breuer, C. K.; Tanel, R. E., et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 60:S513-S516; 1995.
Shirota, T.; Yasui, H.; Shimokawa, H.; Matsuda, T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 24:2295–2302; 2003.
Sodian, R.; Hoerstrup, S. P.; Sperling, J. S.; Daebritz, S. H.; Martin, D. P.; Schoen, F. J.; Vacanti, J. P.; Mayer, J. E. Tissue engineering of heart valves: in vitro experiences. Ann. Thorac. Surg. 70:140–144; 2000.
Woodward, S. C.; Brewer, P. S.; Moatamed, F.; Schindler, A.; Pitt, C. G. The intracellular degradation of poly(epsilon-caprolactone). J. Biomed. Mater. Res. 19:437–444; 1985.
Zimmermann, W. H.; Eschenhagen, T. Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 8:259–269; 2003.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, H., Radisic, M., Lim, J.O. et al. A novel composite scaffold for cardiac tissue engineering. In Vitro Cell.Dev.Biol.-Animal 41, 188–196 (2005). https://doi.org/10.1290/0411071.1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/0411071.1